Tolimidone

DB16841InvestigationalSmall molecule

Tolimidone: Overview.

Mechanism: Pharmacologically active on Tyrosine-protein kinase Lyn
Curator reviewed
Formula / weight: C₁₁H₁₀N₂O₂ · 202.213 g/mol (avg)
Code names: CP-26154 · MLR-1023 · NSC-314335

Resolves to

Compound

Structure

InChIKeyHJQILFPVRNHTIG-UHFFFAOYSA-NSMILESCC1=CC=CC(OC2=CNC(=O)N=C2)=C1

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Tolimidone, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.